Level D· Scientific groundwork from lab and animal studiesLaboratory StudyPubMed

Effect of ADSCs-Exos on Pg-LPS-Induced Osteoclastogenesis in an In Vitro Inflammatory Model.

Luo S., Ma S., Ao M., Wang Y., Li W., Sun J.

Laboratory Study on Chronic Inflammation, published in Oral Dis (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
Oral Dis (2026)
Country
Denmark
Reported sample size
—
Source database
PubMed
PMID
42108521
DOI
10.1111/odi.70350

Abstract (original English)

Background Periodontitis is a chronic inflammatory disorder characterized by tissue degradation and bone loss. Lipopolysaccharide (LPS) accelerates disease progression by host immune activation, inducing localized inflammatory infiltration and osteoclastogenesis, and disrupting bone metabolic homeostasis. Adipose-derived mesenchymal stem cells (ADSCs) exert anti-inflammatory, anti-apoptotic, and regenerative effects via paracrine signaling. Methods ADSCs were isolated using collagenase digestion and characterized by flow cytometry for surface markers and multilineage differentiation potential (assessed by Oil Red O and Alizarin Red S staining). ADSC-Exos were isolated via size-exclusion chromatography and ultrafiltration and characterized by transmission electron microscopy, nanoparticle tracking analysis, and immunoblotting. In a Pg-LPS-induced in vitro periodontitis model, PKH26-labeled ADSC-Exos were internalized by cells, as shown by confocal microscopy. Their effects on osteoclastic markers (TRAP, MMP-9, and COX-2) and signaling mediators (RANK and TRAF6) were evaluated using real-time PCR and western blotting. Results ADSCs-Exos suppressed early osteoclast differentiation in Pg-LPS-induced in vitro periodontitis model. Mechanistic studies revealed that ADSCs-Exos mitigated inflammation by modulating the COX-2/TRAF6/RANK signaling axis. Conclusions This study investigated

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research